Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $46.71. The company's market cap stands at 95.08B, with a P/E ratio of 15.77 and a dividend yield of 5.3%.
As of 2025-11-09, Bristol-Myers Squibb(BMY) stock has fluctuated between $46.32 and $46.99. The current price stands at $46.71, placing the stock +0.8% above today's low and -0.6% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 9.01M, compared to an average daily volume of 18.79M.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.
BMY News
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...
In early November 2025, Bristol-Myers Squibb reported quarterly earnings that surpassed analyst expectations and raised its revenue guidance for the year, while...
Shares of Bristol-Myers Squibb jumped 4% after the company reported third-quarter results that topped forecasts. The company increased its full-year revenue gui...
Analyst ratings
69%
of 29 ratingsMore BMY News
Courtney Breen, an analyst from Bernstein, maintained the Hold rating on Bristol-Myers Squibb. The associated price target remains the same with $58.00. Elevate...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...